Resuscitating a Culture One Beat at a Time
Executive Summary
Its acquisition of privately held Zymed means more to the Healthcare Solutions Group (HSG) of Agilent Technologies than being able to fill a gap in its cardiology business. It is also a part of Agilent's drive to energize its corporate culture following its spin-out of Hewlett-Packard last year. Moreover, in the face of disappointing earnings from HSG and poor near-term growth prospects, Agilent's overall commitment to health care was questioned by Wall Street.
You may also be interested in...
EU Commission Wants Expert Opinion On Prostaglandin Analogs In Eyelash Growth Cosmetics
The Scientific Committee on Consumer Safety will consider available safety data for prostaglandin analogs isopropyl cloprostenate, ethyl tafluprostamide and others with known use in eyelash-growth cosmetic products in the EU. Currently, the substances are not restricted in cosmetic products.
Thermo Fisher Scientific, Hillrom To Acquire Diagnostics Companies To Bolster Portfolios
Thermo Fisher Scientific has agreed to buy Mesa Biotech for $450m in cash and Hillrom will acquire Bardy Diagnostics for $375m in cash. Both deals will add complementary digital health solutions, which may be a continued trend in 2021.
Cosmetic And Personal Care Trademark Review 19 January, 2021
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Need a specific report? 1000+ reports available
Buy Reports